Enveric Biosciences Inc vs Workiva Inc — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while Workiva Inc trades at $55.06 (market cap $3.05B). The key difference: Workiva Inc is far larger — about 573.3× Enveric Biosciences Inc's market cap, and Workiva Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | WK | |
|---|---|---|
Market Cap | $5.32M | $3.05B |
Sector | Health | Technology |
52-Week High | $17.40 | $93.31 |
52-Week Low | $1.28 | $44.31 |
Enterprise Value | $408.82K | $2.98B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Workiva (WK) trades at $54.91, up 2.27% with strong technical momentum and bullish moving average signals. The company demonstrates robust revenue growth with Q1 2026 EPS beating estimates at $0.77 versus $0.66 expected, while maintaining a high gross margin of 79.4%. Analyst sentiment remains overwhelmingly positive with 16 buy ratings and an $71 consensus price target, representing 29% upside potential from current levels.
WK offers compelling growth prospects with expanding profitability and dominant market positioning in compliance software, though elevated valuation multiples (P/E 226.58) and technical overbought conditions warrant caution. The stock faces execution risks in maintaining growth momentum amid competitive pressures, but strong institutional support and consistent earnings beats support the bullish outlook.
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Workiva is a leading provider of cloud-based platforms for complex reporting and compliance. It enables organizations to connect and manage data across financial reporting, ESG (Environmental, Social, and Governance), and GRC (Governance, Risk, and Compliance), serving as a single source of truth for auditable, transparent disclosures to regulators and stakeholders.
Read more on WK →